Organogenesis Holdings (ORGO) EPS (Basic) (QoQ) (2016 - 2026)
Organogenesis Holdings (ORGO) EPS (Basic) (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Organogenesis Holdings | 243.84 Mn | 196.99 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -75.68% |
| Mar 31, 2026 | -236.63% |
| Dec 31, 2025 | 180.95% |
| Sep 30, 2025 | 219.01% |
| Jun 30, 2025 | 43.73% |
| Mar 31, 2025 | -483.15% |
| Dec 31, 2024 | -52.03% |
| Sep 30, 2024 | 172.35% |
| Jun 30, 2024 | -707.22% |
| Mar 31, 2024 | -244.73% |
| Dec 31, 2023 | -54.38% |
| Sep 30, 2023 | -40.43% |
| Jun 30, 2023 | 278.76% |
| Mar 31, 2023 | -139.35% |
| Dec 31, 2022 | 3,404.16% |
| Sep 30, 2022 | -97.56% |
| Jun 30, 2022 | 1,051.46% |
| Mar 31, 2022 | -104.78% |
| Dec 31, 2021 | 51.47% |
| Sep 30, 2021 | -39.35% |